METHOD FOR PREDICTING CARDIOTOXICITY RISK IN CANCER PATIENTS RECEIVING ANTHRACYCLINES CHEMOTHERAPY

The present invention refers to an in vitro method for predicting cardiotoxicity risk in a cancer patient receiving, or susceptible to receive, anthracyclines chemotherapy based on the determination of the expression levels of a combination of 10 circulating miRNAs consisting of miRNA 16-5p, miRNA 2...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Sepúlveda Sanchis, Pilar, Salvador Coloma, Carmen, Ciria Calduch, María, Merken, Jort, A. García, Nahuel, Hervàs Marìn, David, Peiró Molina, Estaban, Castellano Izquierdo, Delia, Caiment, Florian, Sanchez Sanchez, Rafael, Dorronsoro Gonzàlez, Akaitz, Panadero Romero, Joaquín, Montero Argudo, Jose Anastasio, Hernàndiz Martinez, Amparo, Kleinjans, Jos, Carrero Garcìa, Rubèn, Tejedor Gascòn, Sandra, Ontoria Oviedo, Imelda, González-King, Hernán, Santaballa Beltràn, Ana, Heymans, Stephane
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!